Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1081.15
(2.68%)
INR 1081.15
(2.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3 Billion INR | -26.99% |
| 2022 | 4.11 Billion INR | -9.37% |
| 2021 | 4.53 Billion INR | 25.24% |
| 2020 | 3.62 Billion INR | 14.3% |
| 2019 | 3.17 Billion INR | 190.1% |
| 2018 | 1.09 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 607.7 Million INR | 13.86% |
| 2023 Q2 | 795.64 Million INR | -34.03% |
| 2023 Q4 | 533.73 Million INR | 14.16% |
| 2023 FY | 3 Billion INR | -26.99% |
| 2023 Q3 | 467.53 Million INR | -41.24% |
| 2023 Q1 | 1.2 Billion INR | -2.72% |
| 2022 Q3 | 1.07 Billion INR | 49.5% |
| 2022 Q1 | 1.07 Billion INR | 17.32% |
| 2022 FY | 4.11 Billion INR | -9.37% |
| 2022 Q4 | 1.23 Billion INR | 15.09% |
| 2022 Q2 | 720.56 Million INR | -33.0% |
| 2021 Q1 | 1.05 Billion INR | 26.43% |
| 2021 FY | 4.53 Billion INR | 25.24% |
| 2021 Q4 | 916.68 Million INR | -42.73% |
| 2021 Q3 | 1.6 Billion INR | 65.05% |
| 2021 Q2 | 969.84 Million INR | -7.71% |
| 2020 Q4 | 831.15 Million INR | -26.85% |
| 2020 Q3 | 1.13 Billion INR | 53.38% |
| 2020 Q2 | 740.79 Million INR | -19.06% |
| 2020 FY | 3.62 Billion INR | 14.3% |
| 2020 Q1 | 915.21 Million INR | 23.37% |
| 2019 Q2 | 930.04 Million INR | 1.2% |
| 2019 FY | 3.17 Billion INR | 190.1% |
| 2019 Q3 | 579.1 Million INR | -37.73% |
| 2019 Q4 | 741.82 Million INR | 28.1% |
| 2019 Q1 | 919.04 Million INR | 22.83% |
| 2018 Q4 | 748.23 Million INR | 117.18% |
| 2018 Q3 | 344.51 Million INR | 0.0% |
| 2018 FY | 1.09 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 51.239% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 90.536% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 36.231% |
| Granules India Limited | 4.05 Billion INR | 25.913% |
| Indoco Remedies Limited | 984.6 Million INR | -204.977% |
| Achyut Healthcare Limited | 5.73 Million INR | -52286.689% |
| Ajanta Pharma Limited | 8.16 Billion INR | 63.209% |
| Alkem Laboratories Limited | 17.95 Billion INR | 83.278% |
| Alpa Laboratories Limited | 167.76 Million INR | -1689.888% |
| Brooks Laboratories Limited | -195.91 Million INR | 1632.677% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -85.921% |
| Bajaj HealthCare Limited | -837.93 Million INR | 458.359% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -297.964% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 94.607% |
| Eris Lifesciences Limited | 3.91 Billion INR | 23.395% |
| FDC Limited | 3.05 Billion INR | 1.619% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 119.996% |
| Gufic Biosciences Limited | 861.35 Million INR | -248.614% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 28.668% |
| Ipca Laboratories Limited | 5.47 Billion INR | 45.139% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -1236.778% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 1622.072% |
| Lasa Supergenerics Limited | -217.3 Million INR | 1481.833% |
| Laurus Labs Limited | 1.6 Billion INR | -87.032% |
| Lupin Limited | 19.14 Billion INR | 84.315% |
| Mankind Pharma Limited | 19.12 Billion INR | 84.302% |
| Medicamen Biotech Limited | 109.31 Million INR | -2647.054% |
| Medico Remedies Limited | 82.9 Million INR | -3521.808% |
| Megasoft Limited | -127.46 Million INR | 2455.769% |
| NATCO Pharma Limited | 13.88 Billion INR | 78.371% |
| Piramal Pharma Limited | 178.2 Million INR | -1585.076% |
| RPG Life Sciences Limited | 876.6 Million INR | -242.551% |
| Sigachi Industries Limited | 571.8 Million INR | -425.148% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 96.864% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -1086.214% |
| Unichem Laboratories Limited | -704.74 Million INR | 526.085% |
| Wanbury Limited | 559.56 Million INR | -436.634% |
| Windlas Biotech Limited | 581.87 Million INR | -416.061% |
| ZIM Laboratories Limited | 172.46 Million INR | -1641.12% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 92.22% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 177.549% |
| Divi's Laboratories Limited | 16 Billion INR | 81.232% |
| Hester Biosciences Limited | 188.89 Million INR | -1489.711% |
| Procter & Gamble Health Limited | 2 Billion INR | -49.408% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -567.697% |
| Bal Pharma Limited | 73.92 Million INR | -3962.126% |
| Strides Pharma Science Limited | -706.14 Million INR | 525.242% |
| Venus Remedies Limited | 284.9 Million INR | -953.956% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -38.441% |
| Nectar Lifesciences Limited | 49.95 Million INR | -5911.622% |
| Shilpa Medicare Limited | 318.74 Million INR | -842.08% |
| Aarti Drugs Limited | 1.71 Billion INR | -75.174% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -123.373% |
| Suven Life Sciences Limited | -1.05 Billion INR | 385.774% |
| Ind-Swift Limited | 142.31 Million INR | -2010.0% |
| Valiant Laboratories Limited | 3.19 Million INR | -93855.1% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 45.663% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 152.923% |
| Themis Medicare Limited | 435.23 Million INR | -589.923% |
| Hikal Limited | 696.02 Million INR | -331.425% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 81.871% |
| Sequent Scientific Limited | -358.69 Million INR | 937.159% |
| Novartis India Limited | 851.9 Million INR | -252.483% |
| Wockhardt Limited | -4.63 Billion INR | 164.855% |
| Jubilant Pharmova Limited | 771 Million INR | -289.469% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -42240.736% |
| Neuland Laboratories Limited | 3 Billion INR | -0.067% |
| Morepen Laboratories Limited | 961.59 Million INR | -212.272% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -1956.519% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 3410.08% |